XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Net product revenue $ 1,741 $ 148 $ 4,451 $ 438
Royalties and other revenue 9 14 76 64
Total revenues 1,750 162 4,527 502
Operating expenses:        
Cost of sales 71 7 268 15
Research and development, including stock-based compensation of $1,460, $1,337, $4,733, and $3,842, respectively 25,780 17,558 57,795 44,125
Selling, general and administrative, including stock-based compensation of $1,341, $2,561, $7,229, and $7,286, respectively 39,592 32,228 110,844 81,375
Total operating expenses 65,443 49,793 168,907 125,515
Loss from operations (63,693) (49,631) (164,380) (125,013)
Interest and other expense  (4,562) (3,899) (11,721) (7,680)
Interest income and other, net 3,444 3,005 9,464 5,330
Net loss $ (64,811) $ (50,525) $ (166,637) $ (127,363)
Net loss per common share, basic (usd per share) $ (0.18) $ (0.21) $ (0.54) $ (0.60)
Net loss per common share, diluted (usd per share) $ (0.18) $ (0.21) $ (0.54) $ (0.60)
Shares used in computing net loss per common share, basic 361,492 244,925 306,109 213,112
Shares used in computing net loss per common share, diluted 361,492 244,925 306,109 213,112
Other comprehensive loss:        
Unrealized gain (loss) on investments $ 542 $ (13) $ 318 $ 315
Comprehensive loss $ (64,269) $ (50,538) $ (166,319) $ (127,048)